Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GMAB - Genmab reports Q3 worldwide sales of $2.05B for Darzalex

GMAB - Genmab reports Q3 worldwide sales of $2.05B for Darzalex

Genmab A/S
  • Genmab ( GMAB ) has announced Q3 worldwide net trade sales of $2.05B for Darzalex (daratumumab) anti-cancer monoclonal antibody medication, compared with $1.99B generated in Q2 .
  • Net trade sales were USD 1.09B in the U.S. and USD 955M in the rest of the world.
  • Genmab ( GMAB ) receives royalties on the worldwide net sales of Darzalex, both the intravenous and SC products, under the exclusive worldwide license to Johnson & Johnson ( JNJ ) subsidiary Janssen Biotech to develop, manufacture and commercialize daratumumab.

For further details see:

Genmab reports Q3 worldwide sales of $2.05B for Darzalex
Stock Information
Company Name: Genmab A/S
Stock Symbol: GMAB
Market: NYSE
Website: genmab.com
Menu
GMAB GMAB Quote GMAB Short GMAB News GMAB Articles GMAB Message Board
Get GMAB Alerts

News, Short Squeeze, Breakout and More Instantly...